MMDA (drug)

MMDA
Clinical data
Other names	3-Methoxy-4,5-methylenedioxyamphetamine; 5-Methoxy-MDA; 5-MeO-MDA
Routes of; administration	Oral
Drug class	Serotonin 5-HT2A receptor agonist; Serotonin releasing agent; Serotonergic psychedelic; Hallucinogen; Entactogen
ATC code	None;
Legal status
Legal status	AU: S9 (Prohibited substance); BR: Class F2 (Prohibited psychotropics); CA: Schedule I; DE: Anlage I (Authorized scientific use only); UK: Class A; US: Schedule I; UN: Psychotropic Schedule I;
Pharmacokinetic data
Onset of action	20–45 minutes
Duration of action	"Moderate"
Identifiers
	IUPAC name 1-(7-methoxy-1,3-benzodioxol-5-yl)propan-2-amine;
CAS Number	13674-05-0;
PubChem CID	26175;
DrugBank	DB01442;
ChemSpider	24386;
UNII	RG7FY73ZAA;
KEGG	C22812 ;
CompTox Dashboard (EPA)	DTXSID50860757 ;
Chemical and physical data
Formula	C11H15NO3
Molar mass	209.245 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(CC1=CC2=C(C(=C1)OC)OCO2)N;
	InChI InChI=1S/C11H15NO3/c1-7(12)3-8-4-9(13-2)11-10(5-8)14-6-15-11/h4-5,7H,3,6,12H2,1-2H3; Key:YQYUWUKDEVZFDB-UHFFFAOYSA-N;

MMDA, also known as 3-methoxy-4,5-methylenedioxyamphetamine or as 5-methoxy-MDA, is a psychedelic and entactogen of the amphetamine family.